Table 5.
Univariate and multivariate Cox regression model of RF+/- on overall survival
Covariate | Univariate | Multivariate | ||||||
---|---|---|---|---|---|---|---|---|
N | HR | 95% CI | p-value | N | HR | 95% CI | p-value | |
Risk Factor (RF) | 74 | 0.044* | 62 | 0.024* | ||||
No RF | 17 | 1.00 | Ref. | 14 | 1.00 | Ref. | ||
RF+ | 17 | 6.97 | 1.52-31.88 | 0.012* | 15 | 18.19 | 2.08-158.79 | 0.009* |
RF- | 40 | 5.07 | 1.18-21.78 | 0.029* | 33 | 8.75 | 1.09-69.67 | 0.040* |
Treatment | 79 | 0.009* | 62 | 0.001* | ||||
Neoadjuvant | 17 | 1.00 | Ref. | 9 | 1.00 | Ref. | ||
Adjuvant | 51 | 0.29 | 0.13-0.65 | 0.003* | 42 | 0.12 | 0.04-0.38 | <0.001* |
Other | 11 | 0.69 | 0.25-1.89 | 0.479 | 11 | 0.15 | 0.03-0.73 | 0.020* |
Age (≥73years) | 83 | 2.09 | 1.00-4.37 | 0.050* | 62 | 4.13 | 1.27-13.43 | 0.018* |
Tumor size | 74 | 0.026* | ||||||
T0 | 2 | NA | NA | NA | ||||
T1 | 31 | 0.18 | 0.05-062 | 0.007* | ||||
T2 | 35 | 0.16 | 0.04-0.53 | 0.003* | ||||
T3-T4 | 5 | 1.00 | Ref. | |||||
Prominent inflammation (Yes) | 71 | 0.42 | 0.12-1.41 | 0.163 |
N: number of patients; HR: Hazard Ratio; NA: not available (not possible to calculate)
RF+: [(p-NDRG1(N)+ / NDRG1(N)+) / (p-NDRG1(N)- / NDRG1(N)+)]
RF-: p-NDRG1(N)- / NDRG1(N)-.